anmelden
SLI
2.208,68
PKT
+11,41
PKT
+0,52
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.04.15 | Nestlé Neutral | UBS AG | |
| 20.04.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 20.04.15 | Swiss Re Hold | HSBC | |
| 20.04.15 | Nestlé Neutral | Credit Suisse Group | |
| 20.04.15 | Givaudan Equal weight | Barclays Capital | |
| 17.04.15 | Nestlé Hold | S&P Capital IQ | |
| 17.04.15 | Roche buy | Deutsche Bank AG | |
| 16.04.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 16.04.15 | Roche buy | Société Générale Group S.A. (SG) | |
| 16.04.15 | UBS Sector Perform | RBC Capital Markets | |
| 15.04.15 | UBS buy | Citigroup Corp. | |
| 14.04.15 | Novartis neutral | Independent Research GmbH | |
| 14.04.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 14.04.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 14.04.15 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 14.04.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 14.04.15 | Givaudan buy | UBS AG | |
| 14.04.15 | Novartis buy | UBS AG | |
| 13.04.15 | Novartis buy | Jefferies & Company Inc. | |
| 13.04.15 | Roche overweight | JP Morgan Chase & Co. | |
| 13.04.15 | Nestlé Neutral | UBS AG | |
| 13.04.15 | Nestlé Hold | Deutsche Bank AG | |
| 13.04.15 | Givaudan Neutral | Credit Suisse Group | |
| 13.04.15 | Givaudan Hold | HSBC | |
| 13.04.15 | Zurich Insurance Equal weight | Barclays Capital | |
| 13.04.15 | Nestlé Equal weight | Barclays Capital | |
| 13.04.15 | UBS buy | Société Générale Group S.A. (SG) | |
| 13.04.15 | UBS Sell | Société Générale Group S.A. (SG) | |
| 10.04.15 | UBS Strong Buy | S&P Capital IQ | |
| 10.04.15 | Roche kaufen | Independent Research GmbH | |
| 09.04.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 09.04.15 | Nestlé Reduce | Nomura | |
| 08.04.15 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 08.04.15 | Roche Neutral | UBS AG | |
| 08.04.15 | Novartis buy | UBS AG | |
| 07.04.15 | UBS buy | S&P Capital IQ | |
| 07.04.15 | UBS Neutral | Credit Suisse Group | |
| 07.04.15 | Roche Neutral | Citigroup Corp. | |
| 07.04.15 | Givaudan Neutral | Nomura | |
| 07.04.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. |
